Journal of translational medicine · 2025
Single-cell transcriptomic profiling reveals aberrant CD4⁺ naive T cell differentiation driving immune activation in Behçet's uveitis.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Zhang Lu, Sun Yimeng, Yao Xinyu, Yan Chun, Liu Yunfei, Qiao Dijie, Du Ziyu, Hu Cong, Guo Fuying, Meng Ziwei, Chi Wei
Аннотация
BACKGROUND: Behçet's uveitis (BU) is a severe inflammatory ocular manifestation of Behçet's disease, characterized by dysregulated T cell responses. However, the precise mechanisms underlying T cell dysfunction and local immune activation in BU remain poorly understood.
METHODS: We performed single-cell RNA sequencing (scRNA-seq) of peripheral blood mononuclear cells (PBMCs) from BU patients and healthy controls (HCs). These data were integrated with publicly available single-cell transcriptomes of aqueous humor (AH) samples from BU patients. Key findings were validated using qPCR, flow cytometry, and functional assays.
RESULTS: We observed a significant depletion of naive CD4⁺ T cells in BU, accompanied by their differentiation toward terminal effector states characterized by IL-32 and CXCR4 upregulation. IL-32 was identified as a central regulator promoting Th1 and Th17 polarization. Pseudotime trajectory analysis revealed a progressive differentiation process from circulating CD4⁺ T cells to Th17-like inflammatory cells within the AH, enriched for NF-κB and JAK-STAT signaling pathways. CXCR4 expression was associated with T cell chemotaxis into the ocular microenvironment. Cell-cell interaction analyses further highlighted active crosstalk between macrophages and CD4⁺ T cells via the MIF-(CD74+CXCR4/CD44) signaling axis.
CONCLUSION: Our study reveals a coordinated mechanism linking systemic T cell dysregulation to localized ocular inflammation in BU. Targeting IL-32 and CXCR4 may represent promising strategies for restoring immune balance and preventing tissue damage in BU.
METHODS: We performed single-cell RNA sequencing (scRNA-seq) of peripheral blood mononuclear cells (PBMCs) from BU patients and healthy controls (HCs). These data were integrated with publicly available single-cell transcriptomes of aqueous humor (AH) samples from BU patients. Key findings were validated using qPCR, flow cytometry, and functional assays.
RESULTS: We observed a significant depletion of naive CD4⁺ T cells in BU, accompanied by their differentiation toward terminal effector states characterized by IL-32 and CXCR4 upregulation. IL-32 was identified as a central regulator promoting Th1 and Th17 polarization. Pseudotime trajectory analysis revealed a progressive differentiation process from circulating CD4⁺ T cells to Th17-like inflammatory cells within the AH, enriched for NF-κB and JAK-STAT signaling pathways. CXCR4 expression was associated with T cell chemotaxis into the ocular microenvironment. Cell-cell interaction analyses further highlighted active crosstalk between macrophages and CD4⁺ T cells via the MIF-(CD74+CXCR4/CD44) signaling axis.
CONCLUSION: Our study reveals a coordinated mechanism linking systemic T cell dysregulation to localized ocular inflammation in BU. Targeting IL-32 and CXCR4 may represent promising strategies for restoring immune balance and preventing tissue damage in BU.